Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The team found a notable correlation between genetics that predicted low cholesterol and a lower risk of dementia, suggesting ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

Share on PinterestLower your cholesterol to lower your dementia risk, a new study confirms. Image credit: Anna ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...

The negative readout led to a collapse in share price for Alector, which now plans to cut almost half of its workforce while ...

Spirit of the Coast Analytics said Anavex’s Alzheimer’s drug Blarcamesine is likely to gain conditional marketing authorization (CMA) from the European Medicines Agency, citing strong long-term ...

This week’s XBI pullback is healthy. Biotech stocks cannot go up every day. The sector’s recovery off the April lows has been ...

Alector said on Tuesday its experimental drug failed to slow the progression of a rare form of dementia in a late-stage trial, prompting the company to end the study and cut nearly half its workforce.

Scientists think those cholesterol-lowering statins might be doing something else we didn't know about: protecting our brains ...